Get started

IPCA LABORATORIES

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

IPCALAB chart

Key stats

Market capitalization
180.946BINR
Dividends yield (FY)
0.55%
Price to earnings Ratio (TTM)
38.45
Basic EPS (TTM)
18.60INR

About IPCA LABORATORIES

Sector
Health Technology
Industry
Pharmaceuticals: Major
Headquarters
Mumbai
Website
ipca.com
Founded
1949
ISIN
INE571A01038

Ipca Laboratories Ltd. engages in the manufacture, research, and development of pharmaceutical products. Its products include Hydroxychloroquine Sulphate, Artemether and Lumefantrine and Acceclofenac and its combinations. The company was founded on October 19, 1949 and is headquartered in Mumbai, India.

Ideas

IPCALAB Low Risk Big Profit IdeaAs per my analysis, 707 level was strong resistance of NSE:IPCALAB . Now resistance has been brake and sustained above 707. My idea is to take buy entry at level of 707 with stop loss of 666 (-41 Points Risk). My expected upside target would be 766 (+59) & 966 (+259 Points). It could be jackpot id
Long
IPCA LABSHello & Welcome to this analysis The outlook has been down from quarterly, monthly, weekly & daily chart study. Its been in a 2 years downtrend, now near a support but yet to give any reversal confirmation. If this level of 700 fails to hold the next major support comes in at 600. Overall its a w
IPCA Laboratories Positional View Monthly Analysis @ 28 04 2023IPCA Laboratories Positional View @ 28 04 2023 IPCA Laboratories Positional View Monthly Analysis @ 28-04-2023 I Consider this is the Best Opportunity for Ipca Laboratories I will be more Happy if i get another dips, Will Update this idea & decisions in coming months Always Trade What You See no
Long
#IPCALAB #MOREPENLAB #DRREDDY #LAURUSLABS #DIVISLABS #AUROPHARMA#IPCALAB NSE: IPCALAB CMP: 864 TP: 980 SL: 840 TF: <6m RR > ~4.5 times Return > 13% THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTI
Long
IPCALABIPCA is placed @ strong congestion zone which it did clear in the morning but could nt sustain above 900-902 levels, sustaining above 900 with good volumes suggests it ll overcome will give a good breakout, Could be bought here @ cmp 901-902 with menioned stoploss & targets.
Long

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.44Fabulous
Learn more
OANDA
OANDA
Forex
4.52Great
Learn more
FOREX.com
FOREX.com
Forex
4.36Fabulous
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.35Fabulous
Learn more

See all brokers 

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more